C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression

Journal of Affective Disorders

Volumn 163, Issue , 2014, Pages 25-32

  Chocano Bedoya, Patricia O ^a,b   Mirzaei, Fariba ^a   O'Reilly, Eilis J ^a,c   Lucas, Michel ^a,e   Okereke, Olivia I ^a,c,d   Hu, Frank B ^a,c   Rimm, Eric B ^a,c   Ascherio, Alberto ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Department of Epidemiology Harvard School of Public Health ^*  (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITÉ LAVAL   (Canada)

Author keywords

C reactive protein; Depression; Inflammation; Interleukin 6; Prospective study; Soluble tumor necrosis factor receptor 2

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PSYCHOPHARMACOTHERAPY; SMOKING; SOCIAL STATUS;

C-REACTIVE PROTEIN; DEPRESSION; INFLAMMATION; INTERLEUKIN-6; PROSPECTIVE STUDY; SOLUBLE TUMOR NECROSIS FACTOR - RECEPTOR 2;

AGED; ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;

EID: 84898798067     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.03.023     Document Type: Article

References (40)

1. D. Aderka The potential biological and clinical significance of the soluble tumor necrosis factor receptors Cytokine Growth Factor Rev. 7 1996 231 240 (Pubitemid 27200307)
2. B.T. Baune, E. Smith, S. Reppermund, T. Air, K. Samaras, O. Lux, H. Brodaty, P. Sachdev, and J.N. Trollor Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study Psychoneuroendocrinology 37 2012 1521
3. D.M. Berwick, J.M. Murphy, P.A. Goldman, J.E. Ware, A.J. Barsky, and M.C. Weinstein Performance of a five-item mental health screening test Med. Care 29 1991 169 176
4. B. Diniz, A. Teixeira, L. Talib, V.A. Mendona, W. Gattaz, and O. Forlenza Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression J. Psychiatr. Res. 44 2010 917 920
5. Y. Dowlati, N. Herrmann, W. Swardfager, H. Liu, L. Sham, E.K. Reim, and K.L. Lanctot A meta-analysis of cytokines in major depression Biol. Psychiatry 67 2010 446 457
6. J.C. Felger, and F.E. Lotrich Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications Neuroscience 246 2013 199 229
7. D. Gimeno, M. Kivimaki, E.J. Brunner, M. Elovainio, R. De Vogli, A. Steptoe, M. Kumari, G.D. Lowe, A. Rumley, M.G. Marmot, and J.E. Ferrie Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study Psychol. Med. 39 2009 413 423
8. I. Gorai, Y. Taguchi, O. Chaki, R. Kikuchi, M. Nakayama, B.C. Yang, S. Yokota, and H. Minaguchi Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle J. Clin. Endocrinol. Metab. 83 1998 326 332 (Pubitemid 28496500)
9. R. Grassi Oliveira, E. Brietzke, J. Pezzi, R. Lopes, A. Teixeira, and M. Bauer Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder Psychiatry Clin. Neurosci. 63 2009 202 208
10. S.A. Hiles, A.L. Baker, T. de Malmanche, and J. Attia Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis Psychol. Med. 42 2012 2015 2026
11. M.B. Howren, D.M. Lamkin, and J. Suls Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis Psychosom. Med. 71 2009 171 186
12. F. Hu, J. Meigs, T. Li, N. Rifai, and J. Manson Inflammatory markers and risk of developing type 2 diabetes in women Diabetes 53 2004 693 700 (Pubitemid 38270639)
13. E. Karlson, L. Chibnik, S. Tworoger, I. Lee, J. Buring, N. Shadick, J. Manson, and K. Costenbader Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies Arthritis Rheum. 60 2009 641 652
14. D. Kim, K. Masyn, I. Kawachi, F. Laden, and G. Colditz Neighborhood socioeconomic status and behavioral pathways to risks of colon and rectal cancer in women Cancer 116 2010 4187 4196
15. K.Y. Koh, and Byung-Koo Controversies regarding hormone therapy: insights from inflammation and hemostasis Cardiovasc. Res. 70 2006 22 30
16. S.G. Lakoski, and D.M. Herrington Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article Climacteric 8 2005 317 326 (Pubitemid 41617480)
17. Y. Liu, R. Ho, and A. Mak Interleukin (IL)-6, tumour necrosis factor alpha (TNF-a) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression J. Affect. Disord. 139 2012 230 239
18. L. Marchetti, M. Klein, K. Schlett, K. Pfizenmaier, and U.L.M. Eisel Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-d-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway J. Biol. Chem. 279 2004 32869 32881 (Pubitemid 39014747)
19. K.A. Matthews, L.L. Schott, J. Bromberger, J. Cyranowski, S. Everson-Rose, and M.F. Sowers Associations between depressive symptoms and inflammatory/hemostatic markers in women during the menopausal transition Psychosom. Med. 69 2007 124 130 (Pubitemid 46667978)
20. K.A. Matthews, L.L. Schott, J. Bromberger, J. Cyranowski, S. Everson Rose, and M.F. Sowers Are there bi-directional associations between depressive symptoms and C-reactive protein in mid-life women? Brain Behav. Immun. 24 2010 96 101
21. M. McCullough, D. Feskanich, M. Stampfer, E. Giovannucci, E. Rimm, F. Hu, D. Spiegelman, D. Hunter, G. Colditz, and W. Willett Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance Am. J. Clin. Nutr. 76 2002 1261 1271 (Pubitemid 35416561)
22. Y. Milaneschi, A.M. Corsi, B.W. Penninx, S. Bandinelli, J.M. Guralnik, and L. Ferrucci Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study Biol. Psychiatry 65 2009 973 978
23. A.H. Miller, V. Maletic, and C.L. Raison Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression Biol. Psychiatry 65 2009 732 741
24. K. Narita, T. Murata, T. Takahashi, H. Kosaka, N. Omata, and Y. Wada Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy Prog. Neuro-psychopharmacol. Biol. Psychiatry 30 2006 1159 1162 (Pubitemid 43928220)
25. J. Pai, G. Curhan, C. Cannuscio, N. Rifai, P. Ridker, and E. Rimm Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection Clin. Chem. 48 2002 1781 1784
26. J. Pai, T. Pischon, J. Ma, J. Manson, S. Hankinson, K. Joshipura, G. Curhan, N. Rifai, C. Cannuscio, M. Stampfer, and E. Rimm Inflammatory markers and the risk of coronary heart disease in men and women N. Engl. J. Med. 351 2004 2599 2610 (Pubitemid 39628581)
27. J. Pasco, G. Nicholson, L. Williams, F. Jacka, M. Henry, M. Kotowicz, H. Schneider, B. Leonard, and M. Berk Association of high-sensitivity C-reactive protein with de novo major depression Br. J. Psychiatry 197 2010 372 377
28. T. Pearson, G. Mensah, R.W. Alexander, J. Anderson, R. Cannon, M. Criqui, Y. Fadl, S. Fortmann, Y. Hong, G. Myers, N. Rifai, S. Smith, K. Taubert, R. Tracy, and F. Vinicor Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511 (Pubitemid 36158056)
29. T. Pischon, S. Hankinson, G. Hotamisligil, N. Rifai, W. Willett, and E. Rimm Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women Circulation 108 2003 155 160 (Pubitemid 36871296)
30. C. Raison, S. Broadwell, A. Borisov, A. Manatunga, L. Capuron, B. Woolwine, I. Jacobson, C. Nemeroff, and A. Miller Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C Brain Behav. Immun. 19 2005 23 27 (Pubitemid 39592806)
31. P. Ridker Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke Circulation 108 2003 e81 e85
32. E.B. Rimm, E.L. Giovannucci, M.J. Stampfer, G.A. Colditz, L.B. Litin, and W.C. Willett Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals Am. J. Epidemiol. 135 1992 1114 1126 (discussion 1127-1136)
33. B. Rosner, N. Cook, R. Portman, S. Daniels, and B. Falkner Determination of blood pressure percentiles in normal-weight children: some methodological issues Am. J. Epidemiol. 167 2008 653 666 (Pubitemid 351430930)
34. J.C. Stewart, K.L. Rand, M.F. Muldoon, and T.W. Kamarck A prospective evaluation of the directionality of the depression-inflammation relationship Brain Behav. Immun. 23 2009 936
35. T.B. Ustun, J.L. Ayuso Mateos, S. Chatterji, C. Mathers, and C.J.L. Murray Global burden of depressive disorders in the year 2000 Br. J. Psychiatry 184 2004 386 392 (Pubitemid 38624764)
36. C.C. Vitale, A. Gebara, O. Silvestri, A. Wajngarten, M. Cerquetani, E. Fini, M. Ramires, J.A.F. Rosano, and M.C. Giuseppe Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy Menopause 12 2005 552 558
37. W.C. Willett, L. Sampson, M.J. Stampfer, B. Rosner, C. Bain, J. Witschi, C.H. Hennekens, and F.E. Speizer Reproducibility and validity of a semiquantitative food frequency questionnaire Am. J. Epidemiol. 122 1985 51 65 (Pubitemid 15010435)
38. A.M. Wolf, D.J. Hunter, G.A. Colditz, J.E. Manson, M.J. Stampfer, K.A. Corsano, B. Rosner, A. Kriska, and W.C. Willett Reproducibility and validity of a self-administered physical activity questionnaire Int. J. Epidemiol. 23 1994 991 999 (Pubitemid 24331214)
39. Toshiyuki Maegawa Yasui, Masahiko Tomita, Junko Miyatani, Yuka Yamada, Masayo Uemura, Hirokazu Matsuzaki, Toshiya Kuwahara, Akira Kamada, Masaharu Tsuchiya, Naoko Yuzurihara, Mitsutoshi Takeda, and Irahara, Minoru Shuichi Changes in serum cytokine concentrations during the menopausal transition Maturitas 56 2007 396 403
40. A. van den Biggelaar, J. Gussekloo, A.J. de Craen, M. Frolich, M.L. Stek, D.M. Van, and R.G. Westendorp Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age Exp. Gerontol. 42 2007 693 701 (Pubitemid 46756098)